2022 | March / April 2022

EFPIA and Vaccines Europe position on the European Health Emergency preparedness and Response Authority (HERA)

by cyb2025

EFPIA
Brussels, Belgio

ABSTRACT

COVID-19 has shown that coordinated action at EU level is necessary to effectively respond to health emergencies. While during the pandemic the EU reacted to issues as they arose, the creation of HERA is a first step to putting Europe on the front foot in addressing global health threats.
This paper outlines EFPIA and VE’s views and recommendations on a number of elements included in the Commission’s Decision establishing the Health Emergency Preparedness and Response Authority (HERA)] and in the Proposal for a Council Regulation on a framework of measures for ensuring the supply of crisis relevant medical countermeasures in the event of a public health emergency at Union leveP. EFPIA and VE, their national associations and member companies, look forward to working with HERA and all stakeholders towards the shared goal of a safer, healthier and more resilient Europe.

GENERAL PRINCIPLES
Based on the lessons learned from COVID-19 crisis management, points which we believe require particular attention during planning and implementation of preparedness, as well as response activities by HERA, include:

ABOUT THE AUTHOR

EFPIA represents the biopharmaceutical industry operating in Europe. Through its direct membership of 36 national associations, 39 leading pharmaceutical companies and a growing number of small and medium sized enterprises, EFPIA’s mission is to create a collaborative environment that enables our members to innovate, discover, develop and deliver new therapies and vaccines for people across Europe, as well as contribute to the European economy.

Vaccines Europe is a specialised vaccines group within EFPIA. The group represents vaccine companies of all sizes operating in Europe, and currently includes all the major global innovative and research-based vaccine companies, including small and medium-sized enterprises. VE mission is to drive a sustainable and resilient vaccines environment in Europe, protecting people against infectious diseases at all stages of life.

Login